iPSCs : Recent Clinical Insights & Progress
Submit your Abstract to give a Scientific Pitch or present your work as a Poster !
🔬 Topics of Interest
- iPSC-derived therapeutic products and platforms
- Discovery and translational research
- Preclinical and clinical development strategies
- Manufacturing, scale-up, quality, and CMC challenges
- Regulatory pathways for advanced cell therapies
- Clinical applications and patient-centered development
- Enabling technologies, tools, and services
- Innovative approaches supporting access to regenerative therapies
📝 Submission Guidelines
Abstracts must be scientific, non-promotional, and aligned with the scope of the symposium.
Submissions describing commercial products, technologies, or services must provide appropriate scientific context and avoid any commercial bias.
All abstracts will be reviewed by the Symposium Scientific Committee based on:
- Scientific quality
- Innovation
- Relevance to iPSC-derived cell therapies
- Contribution to the advancement of regenerative medicine
📅 Important Information
- ⚠️ Abstract submission deadline: 13th September 2026 ⚠️
- Notification of acceptance: 1st October 2026
- Presentation format: Scientific Pitch and/or Poster
- Submission email: ali.turhan@inserm.fr
This is a unique opportunity to showcase your work, connect with leading international experts, and contribute to the future of iPSC-derived cell therapies and regenerative medicine!